J. Vargaftig

发表

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis

T. Lister, J. Fitzgibbon, D. Bonnet, 2012, Leukemia.

D. Charron, D. Bonnet, C. Tonnelle, 2011, Aging cell.

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

C. Robert, B. Besse, O. Lambotte, 2019, The Lancet. Haematology.

Heterogeneous sensitivity of human Acute Myeloid Leukemia to ß-catenin down-modulation

T. Lister, A. Filby, D. Bonnet, 2011, Leukemia.

The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.

K. Hoang-Xuan, F. Davi, M. Tanguy, 2016, European journal of cancer.

Frequency of Leukemic Initiating Cells does not depend on the xenotransplantation model used

J. Gribben, T. Lister, J. Cavenagh, 2011, Leukemia.

Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study

K. Hoang-Xuan, N. Martin-Duverneuil, J. Bay, 2017, Journal of Neuro-Oncology.

Efficacy and long‐term toxicity of the rituximab‐fludarabine‐cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia

J. Tamburini, A. Delmer, V. Leblond, 2016, American journal of hematology.

O. Lambotte, V. Ribrag, G. Quéré, 2017, European journal of cancer.

Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use

H. Dombret, C. Preudhomme, S. de Botton, 2020, Haematologica.

Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases

K. Hoang-Xuan, V. Leblond, C. Houillier, 2012, Haematologica.

Letter to the editor: Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.

F. Pasquier, F. Rosselli, S. de Botton, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Intervertebral Diskitis Caused by Propionibacterium acnes : A Report of Four Cases

C. Rothschild, J. Viard, H. Zylberberg, 2010 .

Acute myeloid leukemia xenograft success prediction: Saving time

J. Gribben, S. Horswell, D. Bonnet, 2017, Experimental hematology.

IL10 and IL10:IL6 Ratio in CSF Is Useful at Diagnosis but Also in the Assessment of Therapeutic Response in Patients with Primary Central Nervous System Lymphoma (PCNSL)

K. Hoang-Xuan, F. Davi, M. Tanguy, 2014 .

COVID-19 and Pneumocystis jirovecii pneumonia: Back to the basics

E. Longchampt, C. Tcherakian, É. Catherinot, 2021, Respiratory Medicine and Research.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

J. Gribben, T. A. Lister, J. Cavenagh, 2010, Blood.

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells.

C. Bodemer, Aurélie Hermant, R. Liblau, 2006, Blood.

[Bilateral and recurrent facial palsy due to lymphoma: a case report].

J. Vargaftig, C. Bodénez, P. Barre, 2007, Revue de laryngologie - otologie - rhinologie.

Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients.

J. Gribben, A. Filby, V. Imbert, 2016, Cancer research.

Priority Frequency and dynamics of ex-vivo AML-culture initiating cells reflect patients’ outcome.

J. Gribben, A. Filby, V. Imbert, 2015 .

Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results

L. Adès, N. Vey, S. Glaisner, 2018, Blood.

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

V. Leblond, S. Choquet, B. Mahé, 2006 .

Fludarabine Plus Cyclophosphamide and Rituximab In Waldenström's Macroglobulinemia: Results In 55 Patients

J. Tamburini, C. Gardin, A. Delmer, 2010 .

A Niche‐Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia‐Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self‐Renewal Mechanisms

J. Gribben, D. Bonnet, E. Griessinger, 2014, Stem cells translational medicine.

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F. Jardin, T. Petrella, E. Macintyre, 2019, Blood advances.

Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study

P. Gaulard, G. Salles, L. Fornecker, 2023, British journal of haematology.

Absence or Low Expression of Fas-Associated Protein with Death Domain in Acute Myeloid Leukemia Cells Predicts Resistance to Chemotherapy and Poor Outcome

E. Macintyre, O. Legrand, I. Radford‐Weiss, 2004, Cancer Research.

Resistance to Chemotherapy and Poor Outcome Death Domain in Acute Myeloid Leukemia Cells Predicts Absence or Low Expression of Fas-Associated Protein with Updated

E. Macintyre, O. Legrand, I. Radford‐Weiss, 2004 .

Prolonged efficiency of secondary prophylaxis with colistin aerosols for respiratory infection due to Pseudomonas aeruginosa in patients infected with human immunodeficiency virus.

C. Rothschild, J. Viard, H. Zylberberg, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and Safety of Cladribine in Adult Systemic Mastocytosis : A French Multicenter Study of 33 Patients.

C. Bodemer, J. Launay, P. Dubreuil, 2004 .

H. Dombret, P. Fenaux, S. Thépot, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

F. Pasquier, C. Guillouf, F. Rosselli, 2020 .

F. Pasquier, F. Rosselli, S. de Botton, 2021, Annals of Oncology.